March 5, 2026 – As International Women’s Day approaches on March 8, 2026, FACIT is pleased to celebrate the achievements of women-led health and biotech companies that are driving innovative cancer solutions to help patients lead longer and healthier lives.
Tag: women-led
FACIT portfolio company HDAX Therapeutics closes seed financing to target CNS cancers and neuropathies
September 5, 2024 – FACIT congratulates HDAX Therapeutics (“HDAX”) on the closing of a seed financing round to develop their best-in-class HDAC therapeutics for the treatment of a serious cancer conditions. Capital from the investor group, which included an investment from FACIT’s Compass Rose Oncology Fund, will empower HDAX to address the debilitating neuropathic pain frequently experienced by patients with cancer.